United States Biotechnology & Medical Research

Nektar Therapeutics (NKTR)

Track

Track

Nektar Therapeutics executives recently engaged in selling activity, totaling approximately $86,951 in net value over the past quarter. These transactions occurred following an earnings report that exceeded expectations. Despite this positive performance, the stock price has declined by 47.4% over the last ninety days, reflecting broader market volatility for the healthcare firm.
Ticker: NKTR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nektar Therapeutics. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
310.97
Quantity 44,827 -13.7%
Value US$224,993
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
455.64
Quantity 6,564 -0.6%
Value US$3,454,797
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
498.65
Quantity 55,493
Value US$322,164
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
71.98
Quantity 418
Value US$30,087
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
70.00
Quantity 5,681 -36.8%
Value US$397,670
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
65.39
Quantity 5,681
Value US$371,481
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
65.39
Quantity 5,681
Value US$371,481
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
61.65
Quantity 4,500 -7.6%
Value US$277,425
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
60.81
Quantity 5,500 -8.5%
Value US$334,455
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
60.27
Quantity 10,000
Value US$602,700
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
60.71
Quantity 4,697 -6.7%
Value US$285,155
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
59.97
Quantity 5,303 -7.1%
Value US$318,021
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
60.96
Quantity 10,000
Value US$609,600
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
60.71
Quantity 5,538 -26.4%
Value US$336,212
3.8
JONATHAN ZALEVSKY Officer Officer
Transaction date
Proposed sale
Price
59.38
Quantity 5,538
Value US$328,846
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
65.51
Quantity 444 -0.6%
Value US$29,086
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
65.51
Quantity 199 -0.9%
Value US$13,036
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
65.51
Quantity 199
Value US$13,036
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
65.51
Quantity 444
Value US$29,085
4.0
Wilson Mark Andrew Former Officer Officer
Transaction date
Proposed sale
Price
72.64
Quantity 78,510
Value US$5,702,966
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
73.00
Quantity 180 -0.8%
Value US$13,140
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
73.00
Quantity 423 -0.6%
Value US$30,879
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
73.00
Quantity 423
Value US$30,878
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
73.00
Quantity 180
Value US$13,140
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
35.67
Quantity 3,867 -15.3%
Value US$137,936
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
35.67
Quantity 3,867
Value US$137,946
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
58.82
Quantity 2,207
Value US$129,812
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
58.82
Quantity 630
Value US$37,056
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
58.82
Quantity 1,157
Value US$68,053
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
54.28
Quantity 630 -2.8%
Value US$34,196
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
54.28
Quantity 2,207 -3.9%
Value US$119,796
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
54.28
Quantity 1,157 -5.7%
Value US$62,802
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
48.18
Quantity 1,210 -2.4%
Value US$58,298
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
47.49
Quantity 2,156 -4.1%
Value US$102,388
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
46.41
Quantity 1,200 -2.2%
Value US$55,692
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
45.16
Quantity 2,100 -3.7%
Value US$94,836
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
46.69
Quantity 6,666
Value US$311,205
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
39.89
Quantity 1,136 -2.0%
Value US$45,315
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
38.82
Quantity 2,226 -3.7%
Value US$86,413
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
37.87
Quantity 3,304 -5.3%
Value US$125,122
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
38.53
Quantity 6,666
Value US$256,838
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
35.80
Quantity 1,134 -1.8%
Value US$40,597
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
34.40
Quantity 613 -1.0%
Value US$21,087
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
33.54
Quantity 1,496 -2.3%
Value US$50,176
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
32.37
Quantity 1,923 -2.8%
Value US$62,248
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
35.69
Quantity 307 -1.7%
Value US$10,957
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
34.41
Quantity 189 -1.1%
Value US$6,503
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
33.60
Quantity 432 -2.3%
Value US$14,515
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
32.43
Quantity 793 -4.1%
Value US$25,717
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
33.70
Quantity 5,166
Value US$174,119
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
33.52
Quantity 1,721
Value US$57,688
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Planned sale
Price
30.16
Quantity 1,500 -2.2%
Value US$45,240
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Planned sale
Price
30.10
Quantity 485 -2.5%
Value US$14,598
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
30.10
Quantity 485
Value US$14,600
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.16
Quantity 1,500
Value US$45,244
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
26.59
Quantity 725 -3.6%
Value US$19,278
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
26.59
Quantity 676 -3.2%
Value US$17,975
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
26.59
Quantity 1,573 -2.2%
Value US$41,826
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
26.59
Quantity 1,573
Value US$41,826
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
26.59
Quantity 676
Value US$17,975
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
26.59
Quantity 725
Value US$19,278
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
0.67
Quantity 10,712 -3.4%
Value US$7,177
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
0.67
Quantity 23,208 -2.1%
Value US$15,549
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
0.67
Quantity 9,996 -3.1%
Value US$6,697
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
0.67
Quantity 10,712
Value US$7,191
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
0.67
Quantity 9,996
Value US$6,710
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.67
Quantity 23,208
Value US$15,580
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
1.01
Quantity 11,040 -3.3%
Value US$11,150
3.8
Zalevsky Jonathan Chief R&D Officer Officer
Transaction date
Sale
Price
1.01
Quantity 10,300 -3.2%
Value US$10,403
3.9
ROBIN HOWARD W President & CEO Executive Director
Transaction date
Sale
Price
1.01
Quantity 23,774 -2.1%
Value US$24,012
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
1.01
Quantity 11,040
Value US$11,137
3.9
ROBIN HOWARD W Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.01
Quantity 23,774
Value US$23,983
3.8
Zalevsky Jonathan Officer Officer
Transaction date
Proposed sale
Price
1.01
Quantity 10,300
Value US$10,391
4.0
Wilson Mark Andrew Officer Officer
Transaction date
Proposed sale
Price
0.89
Quantity 16,560
Value US$14,801
4.0
Wilson Mark Andrew Chief Legal Officer Officer
Transaction date
Sale
Price
0.89
Quantity 16,560 -4.7%
Value US$14,738
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-18 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
44,827 -13.7%
310.97
US$224,993 		44,827 -13.7% 310.97 US$224,993
2026-08-20 2026-08-18 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
6,564 -0.6%
455.64
US$3,454,797 		6,564 -0.6% 455.64 US$3,454,797
2026-08-18 2026-08-18 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
55,493
498.65
US$322,164 		55,493 498.65 US$322,164
2026-08-18 2026-08-18 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
418
71.98
US$30,087 		418 71.98 US$30,087
2026-07-02 2026-06-30 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
5,681 -36.8%
70.00
US$397,670 		5,681 -36.8% 70.00 US$397,670
2026-06-30 2026-06-30 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,681
65.39
US$371,481 		5,681 65.39 US$371,481
2026-06-30 2026-06-30 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,681
65.39
US$371,481 		5,681 65.39 US$371,481
2026-06-18 2026-06-17 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
4,500 -7.6%
61.65
US$277,425 		4,500 -7.6% 61.65 US$277,425
2026-06-18 2026-06-17 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
5,500 -8.5%
60.81
US$334,455 		5,500 -8.5% 60.81 US$334,455
2026-06-17 2026-06-17 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
10,000
60.27
US$602,700 		10,000 60.27 US$602,700
2026-06-18 2026-06-16 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
4,697 -6.7%
60.71
US$285,155 		4,697 -6.7% 60.71 US$285,155
2026-06-18 2026-06-16 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
5,303 -7.1%
59.97
US$318,021 		5,303 -7.1% 59.97 US$318,021
2026-06-16 2026-06-16 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
10,000
60.96
US$609,600 		10,000 60.96 US$609,600
2026-06-17 2026-06-15 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
5,538 -26.4%
60.71
US$336,212 		5,538 -26.4% 60.71 US$336,212
2026-06-15 2026-06-15 PrS Proposed sale
3.8
JONATHAN ZALEVSKY

Officer

Officer
5,538
59.38
US$328,846 		5,538 59.38 US$328,846
2026-05-21 2026-05-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
444 -0.6%
65.51
US$29,086 		444 -0.6% 65.51 US$29,086
2026-05-21 2026-05-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
199 -0.9%
65.51
US$13,036 		199 -0.9% 65.51 US$13,036
2026-05-19 2026-05-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
199
65.51
US$13,036 		199 65.51 US$13,036
2026-05-19 2026-05-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
444
65.51
US$29,085 		444 65.51 US$29,085
2026-03-13 2026-03-13 PrS Proposed sale
4.0
Wilson Mark Andrew

Former Officer

Officer
78,510
72.64
US$5,702,966 		78,510 72.64 US$5,702,966
2026-02-20 2026-02-18 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
180 -0.8%
73.00
US$13,140 		180 -0.8% 73.00 US$13,140
2026-02-20 2026-02-18 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
423 -0.6%
73.00
US$30,879 		423 -0.6% 73.00 US$30,879
2026-02-18 2026-02-18 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
423
73.00
US$30,878 		423 73.00 US$30,878
2026-02-18 2026-02-18 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
180
73.00
US$13,140 		180 73.00 US$13,140
2026-01-22 2026-01-20 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
3,867 -15.3%
35.67
US$137,936 		3,867 -15.3% 35.67 US$137,936
2026-01-20 2026-01-20 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
3,867
35.67
US$137,946 		3,867 35.67 US$137,946
2025-11-25 2025-11-25 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
2,207
58.82
US$129,812 		2,207 58.82 US$129,812
2025-11-25 2025-11-25 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
630
58.82
US$37,056 		630 58.82 US$37,056
2025-11-25 2025-11-25 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
1,157
58.82
US$68,053 		1,157 58.82 US$68,053
2025-11-25 2025-11-25 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
630 -2.8%
54.28
US$34,196 		630 -2.8% 54.28 US$34,196
2025-11-25 2025-11-25 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,207 -3.9%
54.28
US$119,796 		2,207 -3.9% 54.28 US$119,796
2025-11-25 2025-11-25 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
1,157 -5.7%
54.28
US$62,802 		1,157 -5.7% 54.28 US$62,802
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,210 -2.4%
48.18
US$58,298 		1,210 -2.4% 48.18 US$58,298
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,156 -4.1%
47.49
US$102,388 		2,156 -4.1% 47.49 US$102,388
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,200 -2.2%
46.41
US$55,692 		1,200 -2.2% 46.41 US$55,692
2025-09-11 2025-09-09 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,100 -3.7%
45.16
US$94,836 		2,100 -3.7% 45.16 US$94,836
2025-09-09 2025-09-09 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
6,666
46.69
US$311,205 		6,666 46.69 US$311,205
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,136 -2.0%
39.89
US$45,315 		1,136 -2.0% 39.89 US$45,315
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
2,226 -3.7%
38.82
US$86,413 		2,226 -3.7% 38.82 US$86,413
2025-09-08 2025-09-05 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
3,304 -5.3%
37.87
US$125,122 		3,304 -5.3% 37.87 US$125,122
2025-09-05 2025-09-05 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
6,666
38.53
US$256,838 		6,666 38.53 US$256,838
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,134 -1.8%
35.80
US$40,597 		1,134 -1.8% 35.80 US$40,597
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
613 -1.0%
34.40
US$21,087 		613 -1.0% 34.40 US$21,087
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,496 -2.3%
33.54
US$50,176 		1,496 -2.3% 33.54 US$50,176
2025-09-08 2025-09-04 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,923 -2.8%
32.37
US$62,248 		1,923 -2.8% 32.37 US$62,248
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
307 -1.7%
35.69
US$10,957 		307 -1.7% 35.69 US$10,957
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
189 -1.1%
34.41
US$6,503 		189 -1.1% 34.41 US$6,503
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
432 -2.3%
33.60
US$14,515 		432 -2.3% 33.60 US$14,515
2025-09-08 2025-09-04 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
793 -4.1%
32.43
US$25,717 		793 -4.1% 32.43 US$25,717
2025-09-04 2025-09-04 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
5,166
33.70
US$174,119 		5,166 33.70 US$174,119
2025-09-04 2025-09-04 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
1,721
33.52
US$57,688 		1,721 33.52 US$57,688
2025-09-04 2025-09-02 PlS Planned sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,500 -2.2%
30.16
US$45,240 		1,500 -2.2% 30.16 US$45,240
2025-09-04 2025-09-02 PlS Planned sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
485 -2.5%
30.10
US$14,598 		485 -2.5% 30.10 US$14,598
2025-09-02 2025-09-02 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
485
30.10
US$14,600 		485 30.10 US$14,600
2025-09-02 2025-09-02 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
1,500
30.16
US$45,244 		1,500 30.16 US$45,244
2025-08-21 2025-08-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
725 -3.6%
26.59
US$19,278 		725 -3.6% 26.59 US$19,278
2025-08-21 2025-08-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
676 -3.2%
26.59
US$17,975 		676 -3.2% 26.59 US$17,975
2025-08-21 2025-08-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
1,573 -2.2%
26.59
US$41,826 		1,573 -2.2% 26.59 US$41,826
2025-08-19 2025-08-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
1,573
26.59
US$41,826 		1,573 26.59 US$41,826
2025-08-19 2025-08-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
676
26.59
US$17,975 		676 26.59 US$17,975
2025-08-19 2025-08-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
725
26.59
US$19,278 		725 26.59 US$19,278
2025-05-21 2025-05-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
10,712 -3.4%
0.67
US$7,177 		10,712 -3.4% 0.67 US$7,177
2025-05-21 2025-05-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
23,208 -2.1%
0.67
US$15,549 		23,208 -2.1% 0.67 US$15,549
2025-05-21 2025-05-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
9,996 -3.1%
0.67
US$6,697 		9,996 -3.1% 0.67 US$6,697
2025-05-19 2025-05-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
10,712
0.67
US$7,191 		10,712 0.67 US$7,191
2025-05-19 2025-05-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
9,996
0.67
US$6,710 		9,996 0.67 US$6,710
2025-05-19 2025-05-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
23,208
0.67
US$15,580 		23,208 0.67 US$15,580
2025-02-21 2025-02-19 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
11,040 -3.3%
1.01
US$11,150 		11,040 -3.3% 1.01 US$11,150
2025-02-21 2025-02-19 S Sale
3.8
Zalevsky Jonathan

Chief R&D Officer

Officer
10,300 -3.2%
1.01
US$10,403 		10,300 -3.2% 1.01 US$10,403
2025-02-21 2025-02-19 S Sale
3.9
ROBIN HOWARD W

President & CEO

Executive Director
23,774 -2.1%
1.01
US$24,012 		23,774 -2.1% 1.01 US$24,012
2025-02-19 2025-02-19 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
11,040
1.01
US$11,137 		11,040 1.01 US$11,137
2025-02-19 2025-02-19 PrS Proposed sale
3.9
ROBIN HOWARD W

Officer; Director

Executive Director
23,774
1.01
US$23,983 		23,774 1.01 US$23,983
2025-02-19 2025-02-19 PrS Proposed sale
3.8
Zalevsky Jonathan

Officer

Officer
10,300
1.01
US$10,391 		10,300 1.01 US$10,391
2024-12-26 2024-12-24 PrS Proposed sale
4.0
Wilson Mark Andrew

Officer

Officer
16,560
0.89
US$14,801 		16,560 0.89 US$14,801
2024-12-26 2024-12-24 S Sale
4.0
Wilson Mark Andrew

Chief Legal Officer

Officer
16,560 -4.7%
0.89
US$14,738 		16,560 -4.7% 0.89 US$14,738
Explore more

More insider trading research around Nektar Therapeutics

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America